Cargando…

2843. Maternal Fecal Transplantation to Infants Born by Cesarean Section: Safety and Feasibility

BACKGROUND: A complication of cesarean section delivery is its interference with the normal intestinal colonization of the infant, affecting the development of immune system in early life—a process that has been associated with long-term morbidity, such as allergy and diabetes. We evaluated, in CS-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Helve, Otto, Korpela, Katri, Kolho, Kaija-Leena, Saisto, Terhi, Skogberg, Kirsi, Dikareva, Evgenia, Stefanovic, Vedran, Salonen, Anne, de Vos, Willem M, Andersson, Sture
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809070/
http://dx.doi.org/10.1093/ofid/ofz359.148
_version_ 1783461894335496192
author Helve, Otto
Korpela, Katri
Kolho, Kaija-Leena
Saisto, Terhi
Skogberg, Kirsi
Dikareva, Evgenia
Stefanovic, Vedran
Salonen, Anne
de Vos, Willem M
Andersson, Sture
author_facet Helve, Otto
Korpela, Katri
Kolho, Kaija-Leena
Saisto, Terhi
Skogberg, Kirsi
Dikareva, Evgenia
Stefanovic, Vedran
Salonen, Anne
de Vos, Willem M
Andersson, Sture
author_sort Helve, Otto
collection PubMed
description BACKGROUND: A complication of cesarean section delivery is its interference with the normal intestinal colonization of the infant, affecting the development of immune system in early life—a process that has been associated with long-term morbidity, such as allergy and diabetes. We evaluated, in CS-delivered infants, whether the normal intestinal microbiome and its early life development could be restored by immediate postnatal transfer of maternal fecal microbiota to the newborn. METHODS: Seventeen healthy mothers with planned elective CS were recruited and screened thoroughly for infections, after which 7 mothers were included in the study. A fecal sample was processed according to a transplantation protocol and an aliquot (3–7 mg) was orally administered in breast-milk to the newborn during the first feeding. The infants were followed and fecal samples were gathered during the first 12 weeks of age and subsequently at the age of 8–18 months. RESULTS: The bacterial communities in the fecal samples of the mothers and their offspring were analyzed by sequencing of 16S rRNA amplicons from isolated fecal DNA and compared with that of 11 nontreated CS-delivered infants and 34 vaginally delivered infants. The fecal microbiota at 3 and 12 weeks was similar between treated CS and vaginally delivered infants, in contrast to that of the untreated CS-delivered infants both in overall composition (P = 0.001, Figure) and development of early-life signature bacteria, i.e., bacteroides and bifidobacteria and clostridia (P < 0.0001). CONCLUSION: The seeding of maternal fecal microbes to the newborn intestine can be safely and successfully mimicked in elective CS by transferring a small amount of maternal fecal microbiome orally to the newborn infant. In these infants, this process results in a microbial development that is highly similar to that of the vaginally born infants, and provides support for the hypothesis that microbial colonization in early life results from a maternal fecal transfer. [Image: see text] DISCLOSURES: All Authors: No reported Disclosures.
format Online
Article
Text
id pubmed-6809070
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68090702019-10-28 2843. Maternal Fecal Transplantation to Infants Born by Cesarean Section: Safety and Feasibility Helve, Otto Korpela, Katri Kolho, Kaija-Leena Saisto, Terhi Skogberg, Kirsi Dikareva, Evgenia Stefanovic, Vedran Salonen, Anne de Vos, Willem M Andersson, Sture Open Forum Infect Dis Abstracts BACKGROUND: A complication of cesarean section delivery is its interference with the normal intestinal colonization of the infant, affecting the development of immune system in early life—a process that has been associated with long-term morbidity, such as allergy and diabetes. We evaluated, in CS-delivered infants, whether the normal intestinal microbiome and its early life development could be restored by immediate postnatal transfer of maternal fecal microbiota to the newborn. METHODS: Seventeen healthy mothers with planned elective CS were recruited and screened thoroughly for infections, after which 7 mothers were included in the study. A fecal sample was processed according to a transplantation protocol and an aliquot (3–7 mg) was orally administered in breast-milk to the newborn during the first feeding. The infants were followed and fecal samples were gathered during the first 12 weeks of age and subsequently at the age of 8–18 months. RESULTS: The bacterial communities in the fecal samples of the mothers and their offspring were analyzed by sequencing of 16S rRNA amplicons from isolated fecal DNA and compared with that of 11 nontreated CS-delivered infants and 34 vaginally delivered infants. The fecal microbiota at 3 and 12 weeks was similar between treated CS and vaginally delivered infants, in contrast to that of the untreated CS-delivered infants both in overall composition (P = 0.001, Figure) and development of early-life signature bacteria, i.e., bacteroides and bifidobacteria and clostridia (P < 0.0001). CONCLUSION: The seeding of maternal fecal microbes to the newborn intestine can be safely and successfully mimicked in elective CS by transferring a small amount of maternal fecal microbiome orally to the newborn infant. In these infants, this process results in a microbial development that is highly similar to that of the vaginally born infants, and provides support for the hypothesis that microbial colonization in early life results from a maternal fecal transfer. [Image: see text] DISCLOSURES: All Authors: No reported Disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809070/ http://dx.doi.org/10.1093/ofid/ofz359.148 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Helve, Otto
Korpela, Katri
Kolho, Kaija-Leena
Saisto, Terhi
Skogberg, Kirsi
Dikareva, Evgenia
Stefanovic, Vedran
Salonen, Anne
de Vos, Willem M
Andersson, Sture
2843. Maternal Fecal Transplantation to Infants Born by Cesarean Section: Safety and Feasibility
title 2843. Maternal Fecal Transplantation to Infants Born by Cesarean Section: Safety and Feasibility
title_full 2843. Maternal Fecal Transplantation to Infants Born by Cesarean Section: Safety and Feasibility
title_fullStr 2843. Maternal Fecal Transplantation to Infants Born by Cesarean Section: Safety and Feasibility
title_full_unstemmed 2843. Maternal Fecal Transplantation to Infants Born by Cesarean Section: Safety and Feasibility
title_short 2843. Maternal Fecal Transplantation to Infants Born by Cesarean Section: Safety and Feasibility
title_sort 2843. maternal fecal transplantation to infants born by cesarean section: safety and feasibility
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809070/
http://dx.doi.org/10.1093/ofid/ofz359.148
work_keys_str_mv AT helveotto 2843maternalfecaltransplantationtoinfantsbornbycesareansectionsafetyandfeasibility
AT korpelakatri 2843maternalfecaltransplantationtoinfantsbornbycesareansectionsafetyandfeasibility
AT kolhokaijaleena 2843maternalfecaltransplantationtoinfantsbornbycesareansectionsafetyandfeasibility
AT saistoterhi 2843maternalfecaltransplantationtoinfantsbornbycesareansectionsafetyandfeasibility
AT skogbergkirsi 2843maternalfecaltransplantationtoinfantsbornbycesareansectionsafetyandfeasibility
AT dikarevaevgenia 2843maternalfecaltransplantationtoinfantsbornbycesareansectionsafetyandfeasibility
AT stefanovicvedran 2843maternalfecaltransplantationtoinfantsbornbycesareansectionsafetyandfeasibility
AT salonenanne 2843maternalfecaltransplantationtoinfantsbornbycesareansectionsafetyandfeasibility
AT devoswillemm 2843maternalfecaltransplantationtoinfantsbornbycesareansectionsafetyandfeasibility
AT anderssonsture 2843maternalfecaltransplantationtoinfantsbornbycesareansectionsafetyandfeasibility